Increasing prevalence of infectious diseases and growing adoption of targeted immunotherapy are some of the key factors driving the global market revenue growth.
Increasing prevalence of infectious diseases and growing adoption of targeted immunotherapy are some of the key factors driving the global market revenue growth
According to Emergen Research, the global antibody services market size was USD 1.41 billion in 2020 and is expected to reach USD 3.30 billion in 2028 and register a revenue CAGR of 11.1% during the forecast period, 2021-2028.
Market Dynamics:
The global antibody services market revenue growth is majorly driven by factors such as growing prevalence of infectious diseases worldwide, increasing adoption of targeted immunotherapy, growing demand for protein therapeutics, rise in research & development activities and clinical trials in the pharmaceutical and biotechnology sectors, and increasing number of new product approvals by regulatory authorities. Antibodies are immunoglobulin glycoproteins derived from plasma cells, and IgM and IgG antibodies are among the most commonly utilized classes of antibodies. Antibodies are used to identify certain proteins present in a diseased cell, and they help detect, quantify, and activate specific protein interactions.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/632
Antibody services include various stages of antibody production, including peptide designing & synthesis, carrier protein pairing, animal immunization, hybridoma fusion, serum collection, and antibody purification. Antibody purification services include isolation of monoclonal antibodies (mAbs) from ascites fluid or separation of polyclonal antibodies (pAbs) from serum. Hence, antibody services are used by researchers to develop antibodies for detection of several diseases. Growing demand for advanced medical diagnostic techniques, increasing focus on development of new biomarkers and advanced biologics, growing demand for personalized medicine for treatment of diseases such as cancer, and increasing government and private spending on pharmaceutical R&D and new drug development projects are other major factors contributing to revenue growth of the global antibody services market.
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Antibody Development Segment Accounted for Largest Revenue Share in 2020:
The antibody development segment dominated other segments in terms of revenue share in the global market in 2020. Revenue growth of this segment is mainly attributed to factors such as rapid adoption of targeted immunotherapy, growing demand for protein therapeutics, and rising increasing government investments in drug development and R&D activities in the pharmaceutical and biotechnology sectors.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/632
Bioscience Companies Segment to Account for Fastest Revenue CAGR:
The bioscience companies segment is expected to register the fastest revenue growth rate in the global market over the forecast period. Rising focus on new drug discovery & development, growing demand for effective COVID-19 vaccines during the pandemic, increased government funding for pharmaceutical and biotechnological research & development programs, and rapid advancement of the global healthcare infrastructure are key factors driving this segment’s revenue growth.
North America Market Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America antibody services market held the largest revenue share in the global market in 2020. Rising prevalence of cancer and infectious diseases, rising cases of COVID-19, surge in demand for COVID-19 vaccines and therapeutics, increasing drug development and R&D activities in the pharmaceutical and biotechnology sectors, rising demand for antibody services, and presence of leading market players in the region, including GE Healthcare, Pall Corporation, and Thermo Fisher Scientific, are major factors providing impetus to the regional market revenue growth.
Major Companies in the Global Antibody Services Market Include:
- GE Healthcare
- Thermo Fisher Scientific
- Sartorius AG
- Merck KGaA
- Pall Corporation
- Sigma-Aldrich Corporation
- Eppendorf AG
- Cellab GmbH
- INTEGRA Biosciences AG
- FiberCell Systems Inc.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/antibody-services-market
For the purpose of this report, Emergen Research has segmented the global antibody services market based on service, type, end-use, and region:
Service Outlook (Revenue, USD Billion; 2018–2028)
- Antibody Development
- Antigen Preparation
- Immunization & Hybridoma Production
- Antibody Characterization
- Antibody Production & Purification
- Antibody Fragmentation & Labeling
Type Outlook (Revenue, USD Billion; 2018–2028)
- Monoclonal Antibodies
- Polyclonal Antibodies
End-use Outlook (Revenue, USD Billion; 2018–2028)
- Bioscience Companies
- Bioscience Research Institutions
- Hospitals
- Others
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/632
Region Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Related Published Articles Published by Emergen Research:
Metastatic Cancer Treatment Market
Thermoelectric Materials Market
Unmanned Composite Materials Market
Commercial Vehicle Sensors Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-antibody-services-market